What type of actions are OPDP reviewers responsible for?


According to the Food and Drug Administration (FDA), “Office of Prescription Drug Promotion (OPDP) reviewers have responsibility for reviewing prescription drug advertising and promotional labeling to ensure that the information contained in these promotional materials is not false or misleading.” Some of the key tasks they are charged with include but not limited to: “providing written comments to pharmaceutical sponsors on proposed promotional materials to ensure clear and unambiguous communication of the laws and regulations relating to prescription drug promotion, reviewing complaints about alleged promotional violations, and initiating enforcement actions on promotional materials that are false or misleading.”


CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.